Related Experiment Video
Updated: Aug 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Cholesterol crystal embolization: an atherosclerotic disease with frequent and varied cutaneous manifestations
K G Donohue1, L Saap, V Falanga
1Department of Dermatology and Skin Surgery, Roger Williams Medical Center, Providence, Rhode Island, USA.
Abstract:
In this paper the basic pathogenesis of cholesterol crystal embolization (CCE) is described, its clinical characteristics are presented and diagnosis and therapy are discussed. The main focus will be on the cutaneous manifestations; however, considering that CCE is a systemic illness, findings in other organs will also be highlighted, particularly the commonly involved renal and gastrointestinal systems.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Chronic Kidney Disease II: Clinical Manifestations
Cholecystitis

